Xeroderma pigmentosum: Children of the moon;Xeroderma pigmentosum: Mondscheinkinder

JDDG - Journal of the German Society of Dermatology

Volumn 1, Issue 3, 2003, Pages 191-198

  Herouy, Yared ^a   Krutmann, Jean ^b   Norgauer, Johannes ^a   Schöpf, Erwin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cutaneous neoplasms; Nucleotide excisionrepair system; Ultraviolet(UV) radiation; Xeroderma pigmentosum

Indexed keywords

DEOXYRIBONUCLEASE; DNA;

BASAL CELL CARCINOMA; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL FEATURE; COCKAYNE SYNDROME; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG POTENCY; EXCISION REPAIR; GENE THERAPY; GENETIC DISORDER; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; POIKILODERMA; RADIATION EXPOSURE; RADIOSENSITIVITY; REVIEW; RISK ASSESSMENT; SKIN METASTASIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SUNBURN; TRICHOTHIODYSTROPHY; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

EID: 0037546928     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1610-0387.2003.02032.x     Document Type: Review

References (47)

1. Kaposi M. Xeroderma pigmentosum. Medizinische Jahrbücher, Wien, 1882: 619-633.
2. Susan Mallory. Xeroderma Pigmentosum In: Spitz JL. Disorders with malignant potential: Genodermatoses. Williams & Wilkins, 1995: 152-155.
3. Epstein JH, Fukuyama K, Reed WB, Epstein WL. Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstrated in vivo. Science 1970; 168: 1477-1478.
4. Hölzle E. Xeroderma Pigmentosum. In: Braun-Falco O, Plewig G, Wolff HH: Dermatologie and Venerology. Springer Verlag, 1997: 515-517.
5. Kraemer KH, Lee MM, Scotto J. Early onset of skin and oral cavity neoplasms in xeroderma pigmentosum. Lancet 1982; 1: 56-57.
6. English JSC, Swerdlow AJ. The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 1987; 117: 457-461.
7. Kobayashi M, Satoh Y, Irimajiri T, Mitoh Y, Kozuka T, Sato K, Ichihashi M, Nakanishi T. Skin tumors of xeroderma pigmentosum (I). J Dermatol 1982; 9: 319-322.
8. Tullis GD, Lynde CW, McLean DI, Stewart WD. Multiple melanomas occurring in a patient with xeroderma pigmentosum. J Am Acad Dermatol 1984; 11: 364-368.
9. De Silva BD, Nawroz I, Doherty VR. Angiosarcoma of the head and neck associated with xeroderma pigmentosum variant. Br J Dermatol 1999; 141: 166-167.
10. Robbins JH, Brumback RA, Moshell AN. Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: evidence for a neurodegeneration in later life caused by defective DNA repair. Eur Neurol 1993; 33: 188-190.
11. Robbins JH. Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988; 60: 384-388.
12. Rolig RL, McKinnon PJ. Linking DNA damage and neurodegeneration. Trends Neurosci 2000; 23: 417-424.
13. De Sanctis C, Caccione A. L'idiozia xerodermica. Riv Sper Freniat 1932; 56: 269-292.
14. Nakamura T, Ono T, Yoshimura K, Arao T, Kondo S, Ichihashi M, Matsumoto A, Fujiwara Y. Malignant schwannoma associated with xeroderma pigmentosum in a patient belonging to complementation group D. J Am Acad Dermatol 1991; 25: 349-353.
15. Goyal JL, Rao VA, Srinivasan R, Agrawal K. Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol 1994; 78: 295-297.
16. Vivian AJ, Ellison DW, McGill JI. Ocular melanomas in xeroderma pigmentosum. Br J Ophthalmol 1993; 77: 597-598.
17. Jalali S, Boghani S, Vemuganti GK, Ratnakar KS, Rao GN. Penetrating keratoplasty in xeroderma pigmentosum. Case reports and review of the literature. Cornea 1994; 13: 527-533.
18. Schroeder TM. Relationship between chromosomal instability and leukemia. Hämatol Bluttransfus 1974; 14: 94-96.
19. Tateishi S, Mori S, Sugano T, Hori N, Ohtsuka E, Yamaizumi M. Separation of protein factors that correct the defects in the seven complementation groups of xeroderma pigmentosum cells. J Biochem 1995; 118: 819-824.
20. Copeland NE, Hanke CW, Michalak JA. The molecular basis of xeroderma pigmentosum. Dermatol Surg 1997; 23: 447-455.
21. Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 2001; 61: 8654-8658.
22. Wolff S, Bodycote J, Thomas GH, Cleaver JE. Sister chromatid exchange in xeroderma pigmentosum cells that are defective in DNA excision repair or post-replication repair. Genetics 1975; 81: 349-355.
23. Maeda T, Sato K, Minami H, Taguchi H, Yoshikawa K. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum. J Invest Dermatol 1997; 109: 306-309.
24. Balajee AS, Bohr VA. Genomic heterogeneity of nucleotide excision repair. Gene 2000; 250: 15-30.
25. de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000; 21: 453-460.
26. Trosko JE, Krause D, Isoun M. Sunlight-induced pyrimidine dimers in human cells in vitro. Nature 1970; 22; 8358-8359.
27. Chan GL, Doetsch PW, Haseltine WA. Cyclobutane pyrimidine dimers and (6-4) photoproducts block polymerization by DNA polymerase I. Biochemistry 1985; 24: 5723-5728.
28. Hoeijmakers JH, Egly JM, Vermeulen W. TFIIH: a key component in multiple DNA transactions. Curr Opin Genet Dev 1996; 6: 26-33.
29. de Gruijl FR, van Kranen HJ, Mullenders LH. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol 2001; 63: 19-27.
30. van Steeg H, Mullenders LH, Vijg J. Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice. Mutat Res 2000; 450: 167-180.
31. Sato M, Nishigori C, Lu Y, Zghal M, Yagi T, Takebe H. Far less frequent mutations in ras genes than in the p53 gene in skin tumors of xeroderma pigmentosum patients. Mol Carcinog 1994; 11: 98-105.
32. Morison WL, Bucana C, Hashem N, Kripke ML, Cleaver JE, German JL. Impaired immune function in patients with xeroderma pigmentosum. Cancer Res 1985; 45: 3929-3931.
33. Norris PG, Limb GA, Hamblin AS, Hawk JL. Impairment of natural-killer-cell activity in xeroderma pigmentosum. N Engl J Med 1988; 319: 1668-1669.
34. Ahrens C, Grewe M, Berneburg M, Grether-Beck S, Quilliet X, Mezzina M, Sarasin A, Lehmann AR, Arlett CF, Krutmann J. Photocarcinogenesis and inhibition of intercellular adhesion molecule 1 expression in cells of DNA-repair-defective individuals. Proc Natl Acad Sci U S A 1997; 94: 6837-6841.
35. Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH. Cockayne syndrome and xeroderma pigmentosum. Neurology 2000; 55: 1442-1449.
36. Broughton BC, Berneburg M, Fawcett H, Taylor EM, Arlett CF, Nardo T, Stefanini M, Menefee E, Price VH, Queille S, Sarasin A, Bohnert E, Krutmann J, Davidson R, Kraemer KH, Lehmann AR. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet 2001; 10: 2539-2547.
37. Berneburg M, Lowe JE, Nardo T, Araujo S, Fousteri MI, Green MH, Krutmann J, Wood RD, Stefanini M, Lehmann AR. UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome. EMBO J 2000; 19: 1157-1166.
38. Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 2001; 44: 891-920; quiz 921-924.
39. Lehmann AR. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev 2001; 15: 15-23.
40. Scott RJ, Itin P, Kleijer WJ, Kolb K, Arlett C, Muller H. Xeroderma pigmentosum-Cockayne syndrome complex in two patients: absence of skin tumors despite severe deficiency of DNA excision repair. J Am Acad Dermatol 1993; 29: 883-889.
41. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318: 1633-1637.
42. Braun-Falco O, Galosi A, Dorn M. Tumorprophylaxe bei Xeroderma Pigmentosum mit aromatischem Retinoid (Ro-9359). Der Hautarzt 1982; 33: 445-448.
43. Gleason MC. Xeroderma pigmentosum - five-year arrest after total resurfacing of the face. Plast Reconstr Surg 1970; 46: 577-581.
44. Stege H, Roza L, Vink AA, Grewe M, Ruzicka T, Grether-Beck S, Krutmann J. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci U S A 2000; 97: 1790-1795.
45. Tanaka K, Sekiguchi M, Okada Y. Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus). Proc Nad Acad Sci U S A 1975; 72: 4071-4075.
46. Spirito F, Meneguzzi G, Danos O, Mezzina M. Cutaneous gene transfer and therapy: the present and the future. J Gene Med 2001; 3: 21-31.
47. Khavari PA. Gene therapy for genetic skin disease. J Invest Dermatol 1998; 110: 462-467.